Rapid pneumococcal evolution in response to clinical interventions.
Nicholas J NJ Croucher,
Simon R SR Harris,
Christophe C Fraser,
Michael A MA Quail,
John J Burton,
Mark M van der Linden,
Lesley L McGee,
Anne A von Gottberg,
Jae Hoon JH Song,
Kwan Soo KS Ko,
Bruno B Pichon,
Stephen S Baker,
Christopher M CM Parry,
Lotte M LM Lambertsen,
Dea D Shahinas,
Dylan R DR Pillai,
Timothy J TJ Mitchell,
Gordon G Dougan,
Alexander A Tomasz,
Keith P KP Klugman,
Julian J Parkhill,
William P WP Hanage and
Stephen D SD Bentley
crossref 331(6016):430-4 28 Jan 2011
PMID 21273480
Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.
DOI: 10.1126/science.1198545
Version: za2963e q8zab q8zbc q8zc9 q8zd4 q8ze1 q8zfd q8zg2
Viewers of this paper also looked at these papers: